← FDA Drug Approvals (Drugs@FDA)
BENLYSTA
BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2017-07-20
Drug application
- FDA Application #
BLA761043- Application type
- Biologics License Application
- Brand name
- BENLYSTA
- Generic name
- BELIMUMAB
- Active ingredients
- BELIMUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE LLC
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2017-07-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown